Pathological role of phosphoglycerate kinase 1 in balloon angioplasty-induced neointima formation

Medicine and Dentistry

• Neointima 100%
• Percutaneous Transluminal Angioplasty 100%
• Phosphoglycerate Kinase 100%
• Hypoxia 40%
• Vascular Smooth Muscle Cell 40%
• Restenosis 20%
• Protein Expression 10%
• Ischemia 10%
• Cell Proliferation 10%
• Cell Function 10%
• Small Interfering RNA 10%
• Artery 10%
• Cell Survival 10%
• Hyperplasia 10%
• Phosphoinositide 3-Kinase 10%
• Mechanistic Target of Rapamycin 10%
• Carotid Artery Injury 10%
• Neointimal Hyperplasia 10%
• Arterial Tissue 10%
• Platelet Derived Growth Factor Receptor 10%
• Glycolytic Enzyme 10%
• Cell Energy 10%
• Cell Migration 10%
• Adenosine Triphosphate 10%
• Fibrinogen 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Neointima 100%
• Phosphoglycerate Kinase 100%
• Hypoxia 40%
• Restenosis 20%
• Hyperplasia 20%
• Small Interfering RNA 10%
• Ischemia 10%
• Phosphatidylinositol 3 Kinase 10%
• Platelet Derived Growth Factor Receptor 10%
• Carotid Artery Injury 10%
• Glycolytic Enzyme 10%
• Adenosine Triphosphate 10%
• Fibrinogen 10%
• Mammalian Target of Rapamycin 10%

Biochemistry, Genetics and Molecular Biology

• Phosphoglycerate Kinase 100%
• Enzyme 10%
• Protein Expression 10%
• Small Interfering RNA 10%
• Cell Migration 10%
• In Vivo Study 10%
• Cell Function 10%
• Cell Proliferation 10%
• Cell Survival 10%
• Cell Energy 10%
• Platelet Derived Growth Factor Receptor Beta 10%
• Platelet-Derived Growth Factor Receptor 10%
• Phosphoinositide 3-Kinase 10%
• Adenosine Triphosphate 10%
• Mechanistic Target of Rapamycin 10%